Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades
Related JNJ
ETF Spotlight: Dividend Aristocrat Index
Morgan Stanley Analyst Sees FY15 'Trough' For Johnson & Johnson Pharma Growth
Franchise Fortunes Mark Shifts In Consensus For Marketed Products (Seeking Alpha)
Related JCP
Top 4 NYSE Stocks In The Department Stores Industry With The Highest EPS Growth Forecast For Next Year
Here's Who Benefits The Most If Sears Goes Bankrupt
Will Newell Rubbermaid (NWL) Surprise This Earnings Season? - Analyst Blog (Zacks)

Analysts at Jefferies downgraded Johnson & Johnson (NYSE: JNJ) from “buy” to “hold.” Johnson & Johnson's shares closed at $69.87 on Friday. Johnson & Johnson's trailing-twelve-month profit margin is 12.90%.

Analysts at Credit Suisse downgraded J. C. Penney Company (NYSE: JCP) from “neutral” to “underperform.” J. C. Penney's shares closed at $20.64 on Friday. J. C. Penney's trailing-twelve-month ROE is -8.73%.

Analysts at Goldman Sachs downgraded Garmin Ltd (NASDAQ: GRMN) from “neutral” to “sell.” Garmin's shares closed at $37.01 on Friday. Garmin's trailing-twelve-month ROA is 9.42%.

JP Morgan downgraded Caterpillar (NYSE: CAT) from “overweight” to “neutral.” Caterpillar's shares closed at $84.95 on Friday. Caterpillar's PEG ratio is 0.66.

Latest Ratings for JNJ

DateFirmActionFromTo
Jan 2015BarclaysMaintainsEqual-weight
Jan 2015JefferiesMaintainsHold
Jan 2015BarclaysMaintainsEqual-weight

View More Analyst Ratings for JNJ
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (GRMN + CAT)

Around the Web, We're Loving...

Get Benzinga's Newsletters